UPDATE : Monday, September 7, 2020
상단여백
Pfizer strives to save blockbuster anti-smoking drug
Pfizer Korea is struggling hard to maintain the No. 1 status of anti-smokin...
by So Jae-hyeon  |  2018-05-28 11:57
라인
Korean drugmakers raid ‘pharmerging’ markets
Domestic pharmaceutical companies are accelerating their moves to enter the...
by So Jae-hyeon  |  2018-05-25 14:32
라인
Local drugs to challenge Parkinson’s disease treatment Azilect
Korean drugmakers are preparing to release modified and generic drugs of Az...
by So Jae-hyeon  |  2018-05-23 15:42
라인
Dongwha, Hugel boost Q1 earnings under new CEO
Seven drugmakers with new CEOs this year showed mixed results in the first-...
by So Jae-hyeon  |  2018-05-17 11:45
라인
Hanyang rheumatic disease hospital to focus on intractable diseases
Celebrating its 20th anniversary this year, Hanyang University Hospital for...
by So Jae-hyeon  |  2018-05-16 15:21
라인
Warm inter-Korean relations may benefit GC Pharma, Dong-A ST
The South Korean pharmaceutical industry is paying keen attention to which ...
by So Jae-hyeon  |  2018-05-15 15:50
라인
‘FDA is adapting to fast-changing digital healthcare’
The Korean healthcare system and regulations need to change, in line with t...
by So Jae-hyeon  |  2018-05-11 16:22
라인
‘Open innovation a must in new drug development'
The government and pharmaceutical experts from the business, academic, rese...
by So Jae-hyeon  |  2018-05-10 16:05
라인
How are Korean drugmakers faring in US?
Major Korean drugmakers such as Daewoong Pharmaceutical, Huons, Hanmi Pharm...
by So Jae-hyeon  |  2018-05-09 15:55
라인
Hanmi wins FDA nod for arthritis treatment Hyalrheuma
Hanmi Pharmaceutical said its self-developed arthritis treatment Hyalrheuma...
by So Jae-hyeon  |  2018-05-09 11:59
라인
Boryung’s antihypertensive drug Kanarb tops output among new drugs
Boryung Pharmaceutical’s antihypertensive treatment Kanarb ranked No. 1 in ...
by So Jae-hyeon  |  2018-05-08 16:05
라인
Daewoong to seek US nod for liver drug Ursa this year
Daewoong Pharmaceutical said its liver drug Ursa was likely to become the c...
by So Jae-hyeon  |  2018-05-08 14:37
라인
Korean pharma firms target rare diseases to enter US market
Domestic pharmaceutical companies are targeting the U.S. market with rare d...
by So Jae-hyeon  |  2018-04-30 16:42
라인
Why is Medipost enhancing cord blood biz?
Medipost is aggressively pushing to encourage customers to extend their umb...
by So Jae-hyeon  |  2018-04-26 16:44
라인
Drugmakers compete to develop liver drugs
Korean pharmaceutical companies are increasingly competing to develop new t...
by So Jae-hyeon  |  2018-04-20 14:18
라인
Blockbuster Remicade losing out to Korean biosimilars in US
Biosimilar drugs developed by Korean pharmaceutical firms are gradually car...
by So Jae-hyeon  |  2018-04-19 15:39
라인
Pharma sector embraces work-life balance
Some companies in the pharmaceutical industry are changing their corporate ...
by So Jae-hyeon  |  2018-04-19 14:25
라인
How are Korean drugmakers performing in China?
The pharmaceutical industry is paying attention to how Korean drugmakers ar...
by So Jae-hyeon  |  2018-04-17 15:12
라인
Will anti-smoking drug Champix still be champion?
Korean drugmakers are expected to roll out generic copies of Pfizer’s smoki...
by So Jae-hyeon  |  2018-04-16 14:46
라인
SillaJen reveals clinical results on Pexa-Vec in UK
SillaJen said it unveiled clinical results of REN022, a phase-2 study on Pe...
by So Jae-hyeon  |  2018-04-13 16:38
-123456-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top